Clinical Research Of Pingxiao Granule In Treating Bronchial Asthma (Wind Phlegm Obstruction Lung)

Through the bronchial asthma (wind phlegm obstruction lung) clinical research, analysis to explore the etiology of the disease pathogenesis, treatment principles, combined with the teacher by learning, summed up instructors for this disease treatment experience. Based on50cases of bronchial asthma with wind phlegm obstruction lung in patients with clinical observation, Verify a tutor’s experience of prescriptions--"Pingxiao Granule" on bronchial asthma with wind phlegm obstructioin patients with clinical efficacy and safety. To further explore bronchial asthma effective treatment of traditional Chinese medicine and new medicine preparation to lay the foundation.Theory discusses part:Focusing on modern medicine for bronchial asthma pathogenesis of understanding and drug therapy situation. Traditional Chinese medicine for bronchial asthma origin, etiology and pathogenesis, syndrome differentiation and treatment of understanding. According to the characteristics of asthma pathogenesis, Combined with "the bronchus asthma TCM syndrome differentiation modernization research", the teacher put forward wind phlegm obstruction lung syndrome is a main pathogenesis of bronchial asthma syndrome type and QuFengHuaTan, TongYangXuanBi is an important therapy in treatment of asthma.Clinical research part:50cases of the Department of respiration of Jiangsu Province Traditional Chinese Medicine Hospital outpatients with asthma diagnosis standard, disease in acute episode period, including some chronic persistent period, TCM syndrome of wind sputum pulmonary syndrome, at the age of18-65patients as research object. Watch "Pingxiao Granule" clinical efficacy and safety, and observe the for the improvement of the lung function.The results showed that the "Pingxiao Granule" for "the wind phlegm obstruction lung type" effective control of asthma symptoms, pulmonary function also improved.